Skip to main content
. 2022 Jun 22;4(1):20210081. doi: 10.1259/bjro.20210081

Table 3.

Associations of MRI signs with high-grade sarcoma for the two readers

Reader 1 Reader 2
Value % High p % High p κ
Deep layer location 0
1
73.7
64.4
0.47 73.7
64.4
0.47 1
Tumour size (>5 cm) 0
1
76.2
62.8
0.28 77.3
61.9
0.21 0.90
Lesion heterogeneity in ≥2/3 of total tumour volume on T1 0
1
64.2
81.8
0.26 68.8
62.5
0.64 0.58
Lesion heterogeneity in ≥2/3 of total tumour volume on FS images 0
1
56.8
84.6
0.019* 58.8
76.7
0.13 0.62
Lesion heterogeneity in ≥2/3 of total tumour volume on T1 FS images 0
1
54.5
79.3
0.040* 56.8
80.8
0.047* 0.35
Tumour enhancement (>51%) on contrast enhanced T1 images 0
1
44.0
81.1
0.002* 44.4
82.9
0.002* 0.67
Tumour haemorrhage 0
1
57.5
83.3
0.033* 58.0
100
0.003* 0.20
Tumour necrosis 0
1
40.0
69.5
0.18 55.6
69.1
0.42 0.21
Areas of low signal on T2 0
1
44.4
83.8
0.001* 38.9
78.3
0.003* 0.30
Present fascia tail sign 0
1
37.0
89.2
<0.001* 55.9
80.0
0.04* 0.23
Absent peritumoural capsule fat sign 0
1
72.2
65.2
0.59 70.3
63.0
0.54 0
Diffuse growth pattern 0
1
65.1
71.4
0.61 68.8
65.6
0.79 0.41
Blurred tumour margins 0
1
47.6
76.7
0.020* 55.6
71.7
0.22 0.38
Presence of peritumoural enhancement on contrast enhanced T1 0
1
45.0
82.5
0.003* 42.1
82.4
0.002* 0.66
Presence of neurovascular invasion 0
1
69.4
60.0
0.50 65.3
73.3
0.56 0.48
Lymphadenopathy 0
1
63.8
100
0.072 64.8
80.0
0.35 0.01